113 related articles for article (PubMed ID: 9284424)
1. [Calcium channel blocker for therapy of patients with hypertension].
Sasaki S; Nakagawa M
Nihon Rinsho; 1997 Aug; 55(8):2061-6. PubMed ID: 9284424
[TBL] [Abstract][Full Text] [Related]
2. The T- and L-type calcium channel blocker (CCB) mibefradil attenuates leg edema induced by the L-type CCB nifedipine in the spontaneously hypertensive rat: a novel differentiating assay.
Major TC; Dhamija S; Black N; Liachenko S; Morenko B; Sobocinski G; Okerberg C; Tinholt P; Madore S; Kowala MC
J Pharmacol Exp Ther; 2008 Jun; 325(3):723-31. PubMed ID: 18326812
[TBL] [Abstract][Full Text] [Related]
3. Mibefradil--a new calcium-channel blocker.
Med Lett Drugs Ther; 1997 Nov; 39(1013):103-5. PubMed ID: 9391500
[No Abstract] [Full Text] [Related]
4. [Introducing mibefradil--a new T-calcium channel blocker].
Internist (Berl); 1997 Dec; 38(12 Suppl Mibefradil):1-4. PubMed ID: 9437250
[No Abstract] [Full Text] [Related]
5. Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967).
Bezprozvanny I; Tsien RW
Mol Pharmacol; 1995 Sep; 48(3):540-9. PubMed ID: 7565636
[TBL] [Abstract][Full Text] [Related]
6. Use of calcium channel blockers in hypertension.
Conlin PR; Williams GH
Adv Intern Med; 1998; 43():533-62. PubMed ID: 9506192
[TBL] [Abstract][Full Text] [Related]
7. Diversity of calcium antagonists.
Pitt B
Clin Ther; 1997; 19 Suppl A():3-17. PubMed ID: 9385501
[TBL] [Abstract][Full Text] [Related]
8. Life-threatening interaction of mibefradil and beta-blockers with dihydropyridine calcium channel blockers.
Mullins ME; Horowitz BZ; Linden DH; Smith GW; Norton RL; Stump J
JAMA; 1998 Jul; 280(2):157-8. PubMed ID: 9669789
[TBL] [Abstract][Full Text] [Related]
9. Calcium channel blockers. Is it time to split the lump?
Materson BJ
Am J Hypertens; 1995 Mar; 8(3):325-9. PubMed ID: 7794584
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin receptor blocker and dihydropyridine calcium channel blocker combinations: an emerging strategy in hypertension therapy.
Oparil S; Weber M
Postgrad Med; 2009 Mar; 121(2):25-39. PubMed ID: 19332960
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular T-type calcium channels: physiological and pharmacological significance.
Triggle DJ
J Hypertens Suppl; 1997 Dec; 15(5):S9-15. PubMed ID: 9481611
[TBL] [Abstract][Full Text] [Related]
12. Mibefradil, a pharmacologically distinct calcium antagonist.
Ernst ME; Kelly MW
Pharmacotherapy; 1998; 18(3):463-85. PubMed ID: 9620098
[TBL] [Abstract][Full Text] [Related]
13. Comparison of L-type and mixed L- and T-type calcium channel blockers on kidney injury caused by deoxycorticosterone-salt hypertension in rats.
Baylis C; Qiu C; Engels K
Am J Kidney Dis; 2001 Dec; 38(6):1292-7. PubMed ID: 11728963
[TBL] [Abstract][Full Text] [Related]
14. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
Burnier M; Pruijm M; Wuerzner G
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
[TBL] [Abstract][Full Text] [Related]
15. Steady-state trough plasma mibefradil concentrations and correlation to blood pressure response in hypertensive patients with chronic renal disease.
Pordy R; Woittiez A
Int J Clin Pharmacol Res; 1998; 18(3):105-8. PubMed ID: 9825266
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulating effects of second-generation calcium channel blockers on experimental heart transplantation.
Lapointe N; Chen H; Qi S; Xu D; Daloze P; Dumont L
Eur Surg Res; 1999; 31(3):259-66. PubMed ID: 10352354
[TBL] [Abstract][Full Text] [Related]
17. T-type and L-type calcium channel blockers exert opposite effects on renin secretion and renin gene expression in conscious rats.
Wagner C; Krämer BK; Hinder M; Kieninger M; Kurtz A
Br J Pharmacol; 1998 Jun; 124(3):579-85. PubMed ID: 9647484
[TBL] [Abstract][Full Text] [Related]
18. Profound symptomatic bradycardia associated with combined mibefradil and beta-blocker therapy.
Rogers R; Prpic R
Med J Aust; 1998 Oct; 169(8):425-7. PubMed ID: 9830391
[TBL] [Abstract][Full Text] [Related]
19. The IVS6 segment of the L-type calcium channel is critical for the action of dihydropyridines and phenylalkylamines.
Schuster A; Lacinová L; Klugbauer N; Ito H; Birnbaumer L; Hofmann F
EMBO J; 1996 May; 15(10):2365-70. PubMed ID: 8665843
[TBL] [Abstract][Full Text] [Related]
20. Short-term hemodynamic effects of mibefradil in dogs with chronic heart failure: comparison with diltiazem.
Shimoyama H; Sabbah HN; Tanimura M; Borzak S; Goldstein S
J Pharmacol Exp Ther; 1998 May; 285(2):746-52. PubMed ID: 9580622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
